<DOC>
	<DOCNO>NCT02587624</DOCNO>
	<brief_summary>Prospective observational single center trial , evaluate safety , radiation exposure efficacy remote magnetic catheter ablation atrial fibrillation daily routine .</brief_summary>
	<brief_title>Remote MAGNetic Catheter Ablation Atrial Fibrillation</brief_title>
	<detailed_description>Background : Since first description 1998 catheter-interventional ablation ( CA ) evolve standard treatment symptomatic drug-refractory atrial fibrillation ( AF ) . Ablation efficacy also complication percentage radiation exposure influence several factor , among patient age , body weight , type duration AF , underling cardiac disease well use ablation method , technology experience operator . The objective develop system remote magnetic catheter navigation ( RMN ) improve efficacy safety complex ablation procedure reduce radiation exposure . However , convince data support theory still lack . Aim : To evaluate efficacy , safety profile / complication rate radiation exposure serial ablation procedure paroxysmal persistent AF well repeat intervention base remote magnetic navigation 3-D image integration assessment learn curve complex technology . Design : single center observational registry , analytical questioning , non-randomized , non-controlled , blind , consecutive patient inclusion Study population : Inclusion criterion : Consecutive patient class I class IIa indication CA symptomatic atrial fibrillation accord current guideline . Exclusion criterion : - Contraindication AF catheter ablation - Contraindication RMN procedure . ( These patient may undergo AF ablation another technology , e.g . cryo-balloon ablation ) . - Age &lt; 18 year , gravidity Endpoints Primary endpoint Safety : - The number peri-procedural major complication . - Adverse event classify accord 2012 Expert consensus statement catheter surgical ablation AF [ Calkins H et al . 2012 HRS/EHRA/ECAS Expert Consensus Statement Catheter Surgical Ablation Atrial Fibrillation . Europace ( 2012 ) 14 , 528-606 doi:10.1093/europace/eus027 ] . Secondary endpoint Efficacy - Acute : number successfully isolated pulmonary vein . - Mid-term : freedom atrial tachyarrhythmia ( atrial fibrillation/atypical atrial flutter/atrial tachycardia ; duration &gt; 30 sec ) 6 month follow-up ( initial blanking period 3 month ) . - Long-term : - Freedom atrial tachyarrhythmia ( duration &gt; 30 sec ) 12 month follow-up ( initial blanking period 3 month ) . - Time first recurrence atrial tachyarrhythmia initial blanking period 3 month . Radiation exposure : - mean effective dose ( ED ) , base measure dose-area-product . Aim show potential RMN reduce mean ED 1.5 mSv daily routine RMN AF ablation procedure - The fluoroscopy parameter document system calibration ( A ) , transseptal access/catheter positioning ( B ) , mapping/ablation ( C ) . Safety : - Number peri-procedural minor complication - Number procedure-related complication 12 month follow-up . Subgroups : - Type AF ( paroxysmal versus non-paroxysmal ) - Type antiarrhythmic drug treatment ( AAD ) - Demonstration low-voltage area / fibrosis - Ablation : pulmonary vein antral isolation ( PVAI ) versus additional substrate modification / box isolation fibrotic area ( BIFA ) - Adipositas ( BMI ≥ 30 kg/m² ) - Transseptal access puncture versus via patent foramen ovale - First ablation versus repeat procedure Randomisation : none Study procedure : Pre-ablation : screening patient , refer catheter ablation AF . Inclusion give informed consent . Oral anticoagulation ( OAC ) least 3 week . Transesophageal echocardiography ( TEE ) patient . Ablation : Non-interrupted OAC , non-vitamin-K antagonist treatment withhold morning ablation . All patient undergo PVAI map fibrotic area , additional substrate modification decision operator . Techniques technology use : RMN : Niobe/Epoch® , Navigant™ , 0.1 Tesla , Stereotaxis Inc. ; fluoroscopy system : Siemens AXIOM-Artis VC12B , 6-1 fps ; non-fluoroscopic mapping ( NFM ) : Carto-RMT , magnetic resonance-image-integration , ( Biosense-Webster Inc. ) ; TEE-guided single transseptal puncture , `` Single catheter ablation '' technique : Navistar-RMT Thermocool ( Biosense-Webster Inc. ) , target temperature 48°C , power limit 40Watts ( posterior leave atrial wall ) 50W , irrigation infusion rate 17 mL/min ; Heparin maintain activate clotting time 300 400 sec . Endpoint : bidirectional PV-block . Post-ablation hospital : OAC continue immediately follow sheath removal ablation minimum 2 month , thereafter accord embolic risk ( CHA2DS2-VASc-risk evaluation ) . 48 hour telemonitoring , echocardiography . Follow : blanking period 3 month . Clinical evaluation 3 , 6 12 month include echocardiography 72-hours Holter . Unscheduled visit complication symptom suggest recurrent tachyarrhythmia .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Consecutive patient class I class IIa indication catheter ablation symptomatic atrial fibrillation accord current guideline . Contraindication AF catheter ablation Contraindication magnetically guide ablation procedure Age &lt; 18 year , gravidity , breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>catheter ablation</keyword>
	<keyword>remote magnetic navigation</keyword>
</DOC>